Fierce Pharma Engage 2025

When it comes to maximizing asset value and securing funding, a compelling commercialization strategy is as important as strong science. In this session, we’ll discuss how new approaches to asset development which wholistically integrate both clinical and commercial considerations can de-risk development costs, maximize uptake, and help support a better value creation narrative for investors or other key stakeholders.